MS: Busting the Myths
May 30, 2022 | Advocacy, Life with MS, Treatments
We are excited to announce that following 7 years of relentless advocacy by Multiple Sclerosis NZ (MSNZ), Pharmac have opened the consultation process to increase earlier access to treatments for relapsing remitting MS. We now need YOUR HELP to get […]
May 23, 2022 | Media, Treatments
Media article: 19 May 2022 Pharmac welcomes the $191 million increase to its pharmaceutical budget over the next two years. It is already working its way through the medicines options for investment (OFI) list, looking at what agreements it can […]
December 6, 2021 | Advocacy, Media, Uncategorised
Neil Woodhams, President of MSNZ, welcomed the interim findings of the Pharmac Review released last week. The full report can be found here: https://pharmacreview.health.govt.nz › interim-report. The report highlights the problems MSNZ has experienced over many years in its dealings with […]
September 14, 2021 | Advocacy, Media, Study, Uncategorised
Media Release: 14 September 2021 (For Immediate Release) A new trans-Tasman study has highlighted alarming health inequities between New Zealand patients living with multiple sclerosis (MS) and their Australian counterparts — adding fuel to the ongoing fight for Pharmac to […]
May 26, 2021 | Advocacy
Multiple Sclerosis NZ received several reports from concerned patients regarding the ambiguity of the Special Authority Criteria for DMTs. With the support of Dr John Mottershead, Pharmac were approached for clarification. Concern centred around whether bilateral aids qualify for use […]